Illumina's Q4 Revenues Rise 45 Percent

Illumina's consumables revenues grew 26 percent year over year to $132 million for the quarter, driven primarily by sequencing products, while microarray instrument sales jumped more than 100 percent.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories